Home › Chronic Progressive Multiple Sclerosis › Florida › Orlando
Chronic Progressive Multiple Sclerosis clinical trials in Orlando, FL
4 studies for Chronic Progressive Multiple Sclerosis are looking for participants at sites in and around Orlando (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
RecruitingPhase 3
- Neurology Associates, Maitland · 6 mi away
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
RecruitingPhase 3
- Neurological Services of Orlando, Orlando
- Neurology Associates, PA, Maitland · 6 mi away
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
RecruitingPhase 4
- Neurology Associates, PA, Maitland · 6 mi away
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
RecruitingPhase 3
- Orlando Health Clinical Trials, Orlando
- Comprehensive Neurology Clinic, Orlando
- Neurology Associates PA, Maitland · 6 mi away
- and 1 more
Chronic Progressive Multiple Sclerosis trials in other cities
- Tampa, FL4 studies
- Kansas City, KS4 studies
- Memphis, TN4 studies
- St. Louis, MO4 studies
- Chicago, IL4 studies
- Raleigh, NC3 studies
- Dallas, TX3 studies
- Columbus, OH3 studies
- Scottsdale, AZ3 studies
- Burbank, CA3 studies
- Greenville, SC3 studies
- New York City, NY3 studies
Other studies in Orlando
- Non-Small Cell Lung Cancer47 studies
- Obesity33 studies
- Alzheimer's Disease29 studies
- Metastatic Cancer28 studies
- Overweight27 studies
- Type 2 Diabetes25 studies
- Ovarian Cancer24 studies
- Cancer (all types)24 studies
- Breast Cancer23 studies
- Lung Cancer23 studies
- Ulcerative Colitis21 studies
- Colorectal Cancer21 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.